Fundraising Fox

Protea Biosciences Group

Morgantown, US · Delaware corporation

Biotech

Founders & leadership

ST
Stephen TurnerChief Executive Officer and Chairman of the Board
MP
Matthew PowellVice President, Research & Development
GK
Gregory KilbyVice President, Operations
EH
Edward HughesChief Financial Officer
AB
Alessandro BaldiVice President and General Manager
SO
STEVE O'LOUGHLINVICE PRESIDENT OF CORPORATE FINANCE AND INVESTOR RELATIONS

Board

JA
Josiah AustinBoard director
SA
Steve AntolineBoard director
CA
C. ANDREW ZULAUFBoard director
LH
Leonard HarrisBoard director
SS
Scott SegalBoard director
ER
Ed RobersonBoard director

Reported raises · per SEC filings

Form D private placements

$9.3M disclosed across 8 rounds · 2011–2016

▶$631.7KraisedNov 2016 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick GallagherDirector
  • Josiah T. AustinDirector
  • Ed RobersonDirector
  • Stephen A. TurnerExecutive Officer, Director
  • Steve HarrisDirector
  • David HalversonExecutive Officer
  • Steve AntolineDirector
  • Matthew PowellExecutive Officer
  • Scott SegalDirector
  • Maged ShenoudaDirector
  • Stanley HostlerExecutive Officer, Director
Offering amount
$5M
Amount sold
$631.7K
Minimum investment
$10K
Sales commissions
$95.8K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
Nov 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$691KraisedJun 2016 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Leonard HarrisDirector
  • Gregory KilbyExecutive Officer
  • Scott SegalDirector
  • Stanley HostlerExecutive Officer, Director
  • Stephen TurnerExecutive Officer, Director
  • Ed RobersonDirector
  • Matthew PowellExecutive Officer
  • Maged ShenoudaDirector
  • Josiah T. AustinDirector
  • Patrick GallagherDirector
Offering amount
$2.5M
Amount sold
$691K
Minimum investment
$50K
Sales commissions
$82.9K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$452.5KraisedSep 2015 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott SegalDirector
  • Gregory KilbyExecutive Officer
  • Ed RobersonDirector
  • Maged ShenoudaDirector
  • Stanley HostlerExecutive Officer, Director
  • Stephen A. TurnerExecutive Officer, Director
  • Leonard HarrisDirector
  • Josiah T. AustinDirector
  • Matthew PowellExecutive Officer
  • Patrick GallagherDirector
Offering amount
$4M
Amount sold
$452.5K
Minimum investment
$100K
Sales commissions
$52.5K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJun 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Leonard HarrisDirector
  • Matthew PowellExecutive Officer
  • Stephen TurnerExecutive Officer, Director
  • Gregory KilbyExecutive Officer
  • Stanley HostlerExecutive Officer, Director
  • Scott SegalDirector
  • Josiah AustinDirector
  • Ed RobersonDirector
  • Patrick GallagherDirector
  • Maged ShenoudaDirector
Offering amount
$2M
Amount sold
$2M
Minimum investment
$20K
Sales commissions
$240K
Finders' fees
$200K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
May 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4MraisedNov 2014 · 57 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • EDWARD HUGHESExecutive Officer
  • SCOTT SEGALDirector
  • RODERICK JACKSONDirector
  • LEONARD HARRISDirector
  • MATTHEW POWELLExecutive Officer
  • STEVE O'LOUGHLINExecutive Officer
  • JOSIAH T. AUSTINDirector
  • STANLEY HOSTLERExecutive Officer, Director
  • GREG KILBYExecutive Officer
  • ED ROBERSONDirector
  • STEPHEN TURNERExecutive Officer, Director
  • C. ANDREW ZULAUFDirector
  • STEVE ANTOLINEDirector
Offering amount
$12M
Amount sold
$4.4M
Sales commissions
$465.3K
Proceeds to insiders
$643K
First sale
Oct 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$175KraisedApr 2014 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ED ROBERSONDirector
  • STANLEY HOSTLERExecutive Officer, Director
  • C. ANDREW ZULAUFDirector
  • STEVE ANTOLINEDirector
  • RODERICK JACKSONDirector
  • EDWARD HUGHESExecutive Officer
  • JOSIAH T. AUSTINDirector
  • SCOTT SEGALDirector
  • GREG KILBYExecutive Officer
  • STEPHEN TURNERExecutive Officer, Director
  • MATTHEW POWELLExecutive Officer
  • LEONARD HARRISDirector
  • JOHAN (THIJS) M. SPOORDirector
Offering amount
$1.1M
Amount sold
$175K
First sale
Apr 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$600KraisedApr 2014 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • GREG KILBYExecutive Officer
  • LEONARD HARRISDirector
  • STEPHEN TURNERExecutive Officer, Director
  • SCOTT SEGALDirector
  • C. ANDREW ZULAUFDirector
  • EDWARD HUGHESExecutive Officer
  • JOSIAH T. AUSTINDirector
  • MATTHEW POWELLExecutive Officer
  • JOHAN (THIJS) M. SPOORDirector
  • STANLEY HOSTLERExecutive Officer, Director
  • RODERICK JACKSONDirector
  • STEVE ANTOLINEDirector
  • ED ROBERSONDirector
Offering amount
$900K
Amount sold
$600K
First sale
Apr 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$280KraisedJan 2012 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew PowellExecutive Officer
  • Daniel FlynnDirector
  • Leonard HarrisDirector
  • Scott SegalDirector
  • Tom ClarkDirector
  • Stephen TurnerExecutive Officer, Director
  • Steve AntolineDirector
  • Edward HughesExecutive Officer
  • Stanley HostlerExecutive Officer, Director
  • Alessandro BaldiExecutive Officer
  • Ed RobersonDirector
  • Roderick JacksonDirector
Offering amount
$10M
Amount sold
$280K
Placement agents
Brookline Securities LLC
First sale
Dec 2011
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Protea Biosciences Group - Securities Investigationwhitesecuritieslaw.com · Nov 2017Protea Biosciences Group, Inc announced that it expects to receive $3.31 million in funding from El Coronado Holdings LLC | MarketScreenermarketscreener.com · Nov 2012

Frequently asked questions

Who founded Protea Biosciences Group?
Protea Biosciences Group was founded by Stephen Turner.
How much funding has Protea Biosciences Group raised?
Protea Biosciences Group has disclosed $9.3M raised across 8 rounds.
Where is Protea Biosciences Group headquartered?
Protea Biosciences Group is headquartered in Morgantown, US.